How Wolbachia bacteria help protect flies from fungal infections
Breadth and mechanism of Wolbachia-based inhibition of fungal infection in Drosophila
This study looks at how a type of bacteria called Wolbachia helps fruit flies fight off fungal infections, and by understanding this, we hope to find new ways to control diseases like dengue and Zika that are spread by bugs, which could help people stay healthier.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project ID | NIH-10985737 on NIH RePORTER |
What this research studies
This research investigates the interactions between Wolbachia bacteria and their host, Drosophila melanogaster, to understand how these bacteria can inhibit fungal infections. By using a combination of genetic, molecular, and organismal approaches, the study aims to uncover the mechanisms behind this protective effect and the range of pathogens affected. The findings could provide insights into how these bacteria can be utilized in controlling diseases transmitted by arthropods. Patients may benefit indirectly from this research through advancements in vector control strategies for diseases like dengue and Zika.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at risk for diseases transmitted by mosquitoes, such as dengue and Zika.
Not a fit: Patients who are not affected by arthropod-borne diseases or fungal infections may not receive any direct benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for controlling fungal infections and improving vector control methods for arthropod-borne diseases.
How similar studies have performed: Previous research has shown success in using Wolbachia to inhibit viral transmission in arthropods, indicating potential for similar success in fungal infection control.
Where this research is happening
Lawrence, United States
- University of Kansas Lawrence — Lawrence, United States (Active)
Researchers
- Principal investigator: Perlmutter, Jessamyn — University of Kansas Lawrence
- Study coordinator: Perlmutter, Jessamyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.